KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Current Taxes (2023 - 2025)

Historic Current Taxes for Xenon Pharmaceuticals (XENE) over the last 3 years, with Q3 2025 value amounting to $231000.0.

  • Xenon Pharmaceuticals' Current Taxes changed N/A to $231000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $231000.0, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2024, which is 153861.67% up from last year.
  • Xenon Pharmaceuticals' Current Taxes amounted to $231000.0 in Q3 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Current Taxes peaked at $6.6 million during Q1 2025, and registered a low of $231000.0 during Q3 2025.
  • In the last 3 years, Xenon Pharmaceuticals' Current Taxes had a median value of $1.8 million in 2025 and averaged $2.9 million.
  • Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Current Taxes was 153861.67% (2024), while the steepest drop was 153861.67% (2024).
  • Over the past 3 years, Xenon Pharmaceuticals' Current Taxes (Quarter) stood at $347000.0 in 2023, then skyrocketed by 1538.62% to $5.7 million in 2024, then crashed by 95.94% to $231000.0 in 2025.
  • Its Current Taxes stands at $231000.0 for Q3 2025, versus $1.8 million for Q2 2025 and $6.6 million for Q1 2025.